Myosin heavy chain‐perinatal regulates skeletal muscle differentiation, oxidative phenotype and regeneration
The FEBS Journal · 2024
DOI: 10.1111/febs.17085 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2024. Verfasst von Akashi Sharma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Developmental Genetics Laboratory, Regional Centre for Biotechnology (RCB), NCR Biotech Science Cluster, Faridabad, India. Hauptthemen laut MEDLINE: Cell Differentiation, Regeneration, Myosin Heavy Chains, Muscle Development. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: The Wellcome Trust DBT India Alliance, Department of Biotechnology, Ministry of Science and Technology, India, Department of Biotechnology, Government of West Bengal.
Abstract (Originalsprache)
Myosin heavy chain‐perinatal (MyHC‐perinatal) is one of two development‐specific myosin heavy chains expressed exclusively during skeletal muscle development and regeneration. The specific functions of MyHC‐perinatal are unclear, although mutations are known to lead to contracture syndromes such as Trismus‐pseudocamptodactyly syndrome. Here, we characterize the functions of MyHC‐perinatal during skeletal muscle differentiation and regeneration. Loss of MyHC‐perinatal function leads to enhanced differentiation characterized by increased expression of myogenic regulatory factors and differentiation index as well as reduced reserve cell numbers in vitro . Proteomic analysis revealed that loss of MyHC‐perinatal function results in a switch from oxidative to glycolytic metabolism in myofibers, suggesting a shift from slow type I to fast type IIb fiber type, also supported by reduced mitochondrial numbers. Paracrine signals mediate the effect of loss of MyHC‐perinatal function on myogenic differentiation, possibly mediated by non‐apoptotic caspase‐3 signaling along with enhanced levels of the pro‐survival apoptosis regulator Bcl2 and nuclear factor kappa‐B (NF‐κB). Knockdown of MyHC‐perinatal during muscle regeneration in vivo results in increased expression of the differentiation marker myogenin (MyoG) and impaired differentiation, evidenced by smaller myofibers, elevated fibrosis and reduction in the number of satellite cells. Thus, we find that MyHC‐perinatal is a crucial regulator of myogenic differentiation, myofiber oxidative phenotype and regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Developmental Genetics Laboratory, Regional Centre for Biotechnology (RCB), NCR Biotech Science Cluster, Faridabad, India.
- Affiliated to KIIT University, Bhubaneswar, India.
ORCID-Profile: Sam J Mathew
Förderung
- The Wellcome Trust DBT India Alliance
- Department of Biotechnology, Ministry of Science and Technology, India
- Department of Biotechnology, Government of West Bengal
Zitieren
APA
Sharma, A., Zehra, A., & Mathew, S. J. (2024). Myosin heavy chain‐perinatal regulates skeletal muscle differentiation, oxidative phenotype and regeneration. The FEBS Journal. https://doi.org/10.1111/febs.17085
Vancouver
Sharma A, Zehra A, Mathew SJ. Myosin heavy chain‐perinatal regulates skeletal muscle differentiation, oxidative phenotype and regeneration. The FEBS Journal. 2024. doi:10.1111/febs.17085
BibTeX
@article{Sharma2024,
author = {Sharma, Akashi and Zehra, Aatifa and Mathew, Sam J},
title = {Myosin heavy chain‐perinatal regulates skeletal muscle differentiation, oxidative phenotype and regeneration},
journal = {The FEBS Journal},
year = {2024},
doi = {10.1111/febs.17085}
}
EUVIMED